Heartware (HTWR) Sees Q4 Revenue of $68M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
JPMorgan Downgrades Heartware International (HTWR) to Neutral
January 12, 2016 11:06 AM ESTJPMorgan earlier downgraded Heartware International (NASDAQ: HTWR) from Overweight to Neutral with a price target of $39.00 (from $56.00).
For an analyst ratings summary and ratings history on Heartware International click here. For more ratings news on Heartware International click here.
Shares of Heartware International closed at $40.84 yesterday.
... MoreLeerink Affirms HeartWare (HTWR) at 'Outperform' Amid Prelim. Q4 Numbers, ENDURANCE Ambitions
January 12, 2016 8:50 AM ESTLeerink reaffirms HeartWare International, Inc. (Nasdaq: HTWR) at Outperform with a price target of $60 after the company announced preliminary results Monday night.
Analyst Danielle Antalffy commented, ...though yet another MVAD delay appears to be negative, HTWR is submitting its ENDURANCE trial data for... More
